Comprehensive Knee Osteoarthritis Index (CKOAI): Scale Development, Validation and Reliability Testing
NCT ID: NCT03498833
Last Updated: 2019-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2018-04-17
2019-02-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Symptoms, balance, mobility, activities of daily life (ADL) and quality of life (QoL) are to be considered in rehabilitation of the individuals with knee osteoarthritis (IKOA). There are several scales to evaluate subjective perceptions and individual components in patients with osteoarthritis (OA). Till date, no scale is available to measure the combined balance, mobility, ADL and QoL in PKOA.
Objectives:
The objectives of the study are to develop a combined measure of symptoms, balance, mobility, ADL and QoL in PKOA, as comprehensive knee osteoarthritis index (CKOAI) and to validate the scale for its content, reliability and minimum detectable change (MDC)
Methods:
The study consists of a three stages. First stage is the scale (CKOI) item development and validation. This includes domain and item generating through systematic literature search to extract items related symptoms, balance, mobility, ADL and QoL in IKOA based on the International Classification of Functioning, Disability and Health (ICF) and through structured interviews. During scale validation, an expert panel will review the generated domains and items by Delphi Method, which will undergo revision and pilot testing. Based on the responsiveness of pilot testing will be revised finally. Second stage is to test re-test reliability. The third stage is to report the standard error of measurement (SEM) and minimal detectable change (MDC).
Data analysis:
All the domains and items in CKOAI will undergo reliability and criterion-related validity. Minimum 50 IKOA will be evaluated with the scale on two occasions within two weeks to establish test retest reliability. Cronbach's alpha for internal consistency and Intra class correlation coefficient for test retest reliability will be used to determine the degree of consistency of items in the scale. MDC will be calculated using the formulae, SEM = SD x √ (1-reliability) and MDC95 = √2 x (1.9) x (SEM). Significant level will be set at p value less than 0.05 (p \< 0.05) to minimize the type-I error.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Associated With Quality of Life in Knee Osteoarthritis
NCT06760338
The Efficacy of Collaborative Patient Education on Total Knee Arthroplasty
NCT05346822
Instrumental Versus Standard Rehabilitation for Knee Osteoarthritis
NCT06178380
Tele-assessment of the Performance Tests in Patients With Knee Osteoarthritis
NCT06711445
Study on the Rehabilitation Treatment of Knee Osteoarthritis Based on ICF
NCT04951414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of the worldwide leading causes of disability and pain is osteoarthritis. 22% to 39% of 1.252 billion population suffer from osteoarthritis (OA). Hip and knee OA are the most prevalent forms of OA with the overall prevalence of knee OA is 28.7%. This will increase by 33.5% in 2030 due to alarming increase in aging population. Individuals with knee OA (IKOA) are seen with deficits in static and dynamic balance which comprises of impaired proprioception, muscle strength, disturbed postural control and decreased range of motion at knee joint. Furthermore, IKOA have pain and increase physical limitation and functional limitation. Eventually decreasing their quality of life (QoL).
Static balance in IKOA are assessed using several outcome measures such as, timed single-leg stance, functional reach test and variation of postural sway in unipedal or bipedal stance. More than two decade, Berg Balance Scale and Tinetti Performance-Oriented Mobility Assessment (balance subscale) were used to asses dynamic balance. Recently, Community Balance and Mobility Scale (CB\&M) have been validated for the purpose. Isokinetic dynamometer has been in use for the purpose of estimating muscle strength. Proprioception was measured by joint repositioning test. Several researchers explored QoL in IKOA,and combined with functional independence.
Various measures of knee function adopted by International Knee Documentation Committee (IKDC) are subjective in nature. Patient reported problem based rating scale in IKOA with objective scoring is still lacking. There, the purpose of this research project is to develop a rating scale which does combine assessment of balance, mobility, ADL and QoL in IKOA.
Statement of the Problem:
The existing scales could not provide comprehensive assessment for balance, mobility, ADL and QoL in IKOA. Hence, there is a need to develop an objective scale to measure the above domains in IKOA
Purpose of the study:
The purpose of the study is to develop an objective combined assessment of symptoms, balance, mobility, ADL and QoL in IKOA (CKOAI) using systematic approach.
Objectives of the study:
1. To develop scale items and domains of CKOAI
2. To validate the developed scale for content validity
3. To estimate reliability of CKOAI
4. To report SEM and MDC
Procedure:
The study will be of cross-sectional observational study of scale validation. The study protocol was approved by the Institutional Ethics Committee of Maharishi Markandeshwar (Deemed-to-be) University (MMU/IEC/1021) on 8.12.2017. The study will consists of three major phases, comprising of item and domain generation, validation, reliability testing and estimating MDC.
Phase 1: Scale Development
Sub-Phase 1:Domain and item development:
1. Domain and item generating:
using literature search and direct patient interviews.
\- Literature search: English language literature will be searched in databases.
\- Direct interview
2. Grouping item in domain Sub-phase 2: Content Validation
* Using Delphi Method Sub-phase 3: First draft and scoring criteria Sub-phase 4: Pilot test Sub-phase 5: Revision Sub-phase 6: Final draft
Phase 2: Reliability testing
1. Check for internal consistency
2. Intra-rater reliability
3. Test-retest reliability
Phase 3: Estimating SEM and MDC
MDC will be calculated using the formulae, SEM = SD x √ (1-reliability) and MDC95 = √2 x (1.9) x (SEM). Significant level will be set at p≤ 0.05 to minimize the type-I error. For MCID, responsiveness of the scale will be determined on two occasions after regular conventional physiotherapy treatment of two week duration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test-retest reliability testing
Minimum 50 IKOA will be evaluated with the scale on two occasions within two weeks to establish test retest reliability.
Test-retest reliability testing
Set of patient reported outcome measures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test-retest reliability testing
Set of patient reported outcome measures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals with unilateral or bilateral knee osteoarthritis
* Both male and female
* Individuals who able to understand simple command
* Individuals who are willing to participate
Exclusion Criteria
* History of knee arthroscopic surgery within 6 months
* Any neurologic and musculoskeletal condition which affect their movement or balance
* Comorbidities such as cancer or cardiovascular disease
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maharishi Markendeswar University (Deemed to be University)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asir John Samuel
Associate Professor and Research Scholar
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kanimozhi D Narkeesh, PhD
Role: STUDY_DIRECTOR
Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
Ambāla, Haryana, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1211-8513
Identifier Type: OTHER
Identifier Source: secondary_id
L-78484/2018
Identifier Type: REGISTRY
Identifier Source: secondary_id
MMU/IEC/1021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.